Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life threatening cardiovascular disease, and NAFLD/NASH (nonalcoholic fatty liver disease) today announced the pricing of its initial public offering. The shares are expected to begin trading on the […]
With record attendance, the 2015 MVCA Annual Awards Dinner focused on the tremendous growth of the entrepreneurial and investment community in Michigan and the broader Great Lakes Region. Our Executive Director Maureen Miller Brosnan welcomed our members and guests to an evening of celebration and reflection, and took a moment to recognize some special guests in […]
Serial entrepreneurs are the lifeblood of a vibrant, growing venture capital community, and the Great Lakes Region is home to many successful founders who can translate their past experience into growing new companies in this area. Over the past decade, one Michigan entrepreneur and venture capitalist has proven she has the determination to nurture multiple […]
The road from company formation to successful exit is a tenuous one, even when the startup is well-capitalized and quickly finds a profitable niche in the marketplace. For a biotech company developing drug therapies, their survival to test the drug safety and efficacy for many years, sometimes a decade or more, is highly dependent on […]
ANN ARBOR, Mich.—Celebrating “A Year of Exits”, the Michigan Venture Capital Association held its annual awards dinner for its members and guests November 15 in Ann Arbor. The statewide membership organization honored several Michigan venture firms as well as venture capital recipient companies for their successes: MVCA “Michigan 100” Award winner Cerenis Therapeutics of Ann Arbor, […]
Michigan entrepreneurs Rob Malan (Co-founder & Chief Technology Officer, Arbor Networks), Ted Dacko (Former President and CEO, HealthMedia Founder, Arbor Dakota Strategies), Josh Linkner (Founder and Chairman, ePrize Managing Director, Detroit Venture Partners), and Tim Mayleben (President & CEO, Aastrom Biosciences) joined moderator Mina Sooch for a lively panel discussion on the challenges and opportunities […]
ANN ARBOR, Mich.—The Michigan Venture Capital Association (MVCA) celebrated a year of individual, company, and statewide industry achievement at its Annual Dinner held November 7 at the Inn at St. John’s in Plymouth. Over 145 members of the Michigan venture community attended the evening event, where incoming Chairman Tim Petersen introduced members of the organization’s […]
ProNAi Therapeutics, Inc., a private DNAi cancer drug development company, recently concluded its initial human clinical trial of PNT2258. The company also expanded its management team with the recent appointments of board member and venture capital investor Mina Sooch, MBA, as President and CEO, and Dr. Richard Messmann, MD, as Chief Medical Officer.